Advances in optical imaging in the diagnosis of traumatic brain injury
Acta Biomaterialia · 2025-10 · 205 · 105-124
DOI: 10.1016/j.actbio.2025.09.004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Biomaterialia, 2025-10. Verfasst von Qiufang Gong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Advanced Research, Departmrnt of Neurosurgery, Cixi Biomedical Research Institute, Affiliated Cixi Hospital, Wenzhou Medical University…. Hauptthemen laut MEDLINE: Brain Injuries, Traumatic, Optical Imaging. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 126 Literaturangaben. Gefördert von: Zhejiang Province Natural Science Foundation, Natural Science Foundation of Ningbo Municipality.
Abstract (Originalsprache)
Traumatic brain injury (TBI), a leading cause of neurological disability, imposes a critical need for early and precise diagnosis due to its complex pathological heterogeneity, which directly impacts treatment efficacy and patient prognosis. Although conventional imaging techniques (e.g., CT, MRI) provide structural insights, their inherent limitations in molecular specificity, sensitivity for subtle lesions, and real-time dynamic monitoring necessitate the development of complementary approaches. Optical imaging, including fluorescence, bioluminescence, and photoacoustic imaging, have emerged as powerful tools, enabling non-invasive, real-time, and molecular-specific visualization of pathological cascades with high spatiotemporal resolution. In the field of TBI diagnosis, optical imaging has become a research hotspot. In this review, we systematically explore the mechanisms of optical imaging methods and discuss the latest advances in their use for TBI diagnosis and TBI biomarker identification, and further discusses the possible future development of optical imaging in early diagnosis of TBI. STATEMENT OF SIGNIFICANCE: (1) Highlights the limitations of current clinical imaging (CT/MRI) in detecting traumatic brain injury (TBI). (2) Showcases the unique advantages of optical imaging (e.g., fluorescence, photoacoustic, afterglow) for TBI diagnosis. (3) Introduces a timely, interdisciplinary review bridging nanomaterials, optical imaging, and TBI diagnostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Advanced Research, Departmrnt of Neurosurgery, Cixi Biomedical Research Institute, Affiliated Cixi Hospital, Wenzhou Medical University, Ningbo, Zhejiang, 315300, China.
- Institute for Advanced Research, Departmrnt of Neurosurgery, Cixi Biomedical Research Institute, Affiliated Cixi Hospital, Wenzhou Medical University, Ningbo, Zhejiang, 315300, China. Electronic address: crydjb@wmu.edu.…
- School of Physical and Mathematical Sciences, Nanjing Tech University (Nanjing Tech), Nanjing 211816, China. Electronic address: xjsong@njtech.edu.cn.
- Institute for Advanced Research, Departmrnt of Neurosurgery, Cixi Biomedical Research Institute, Affiliated Cixi Hospital, Wenzhou Medical University, Ningbo, Zhejiang, 315300, China. Electronic address: liangchao@wmu.e…
Förderung
- Zhejiang Province Natural Science Foundation
- Natural Science Foundation of Ningbo Municipality
Zitieren
APA
Gong, Q., Deng, L., Ru, J., Wen, L., Zhang, Y., Chen, Z., Wei, X., Dong, J., Song, X., & Liang, C. (2025). Advances in optical imaging in the diagnosis of traumatic brain injury. Acta Biomaterialia, 205, 105-124. https://doi.org/10.1016/j.actbio.2025.09.004
Vancouver
Gong Q, Deng L, Ru J, Wen L, Zhang Y, Chen Z, et al. Advances in optical imaging in the diagnosis of traumatic brain injury. Acta Biomaterialia. 2025;205:105-124. doi:10.1016/j.actbio.2025.09.004
BibTeX
@article{Gong2025,
author = {Gong, Qiufang and Deng, Long and Ru, Jiaxi and Wen, Lutong and Zhang, Yanni and Chen, Zaifeng and Wei, Xiaojie and Dong, Jingbo and Song, Xuejiao and Liang, Chao},
title = {Advances in optical imaging in the diagnosis of traumatic brain injury},
journal = {Acta Biomaterialia},
year = {2025},
volume = {205},
pages = {105--124},
doi = {10.1016/j.actbio.2025.09.004}
}
EUVIMED